✦ LIBER ✦

Protease inhibitor phenotypes and serum alpha-1-antitrypsin levels in patients with COPD: A study from Hong Kong

✍ Scribed by Janette S. Y. KWOK; John W. M. LAWTON; Wing Wai YEW; Chi Hung CHAU; Joseph LEE; Poon Chuen WONG

Book ID: 108964182
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 83 KB
Volume: 9
Category: Article
ISSN: 1323-7799
DOI: 10.1111/j.1440-1843.2004.00560.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relation of functional characteristics a

Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD)

✍ Bojan Zarić; Jelena Stojčević; Ljiljana Andrijević; Ilija Andrijević; Vesna Kuru 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 213 KB

C3A DES ARG and elastase-alpha 1-proteas

C3A DES ARG and elastase-alpha 1-protease inhibitor levels in lavage fluid from patients with adult respiratory distress syndrome

✍ Zheutlin, Lynne M.; Thonar, Eugene J.-M.A.; Lemley-Gillespie, Susan; Jacobs, Eli 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 651 KB

593 A prospective study of the effect of

593 A prospective study of the effect of 5-alpha-reductase inhibitor (dutasteride) treatment on serum free testosterone level and aging male symptoms in Japanese patients with benign prostatic hyperplasia

✍ T. Maeda; E. Kikuchi; M. Hasegawa; T. Ando; Y. Yasumizu; G. Kaneko; H. Nagata; A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB

1142 A PROSPECTIVE STUDY OF THE EFFECT O

1142 A PROSPECTIVE STUDY OF THE EFFECT OF 5-ALPHA-REDUCTASE INHIBITOR (DUTASTERIDE) TREATMENT ON SERUM FREE TESTOSTERONE LEVEL AND AGING MALE SYMPTOMS IN JAPANESE PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

✍ Maeda, Takahiro; Kikuchi, Eiji; Hasegawa, Masanori; Kaneko, Gou; Shinoda, Kazuno 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

Risk factors and occurrence of rash in H

Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mμL)

✍ M Floridia; R Bucciardini; V Fragola; CM Galluzzo; G Giannini; MF Pirillo; R Ami 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB